ZBI
SIOX

Ziff Brothers Investments’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Ziff Brothers Investments’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$13.4M Hold
119,997
– – 5.04% 12
2016
Q2 		$12.3M Buy
+119,997
New +$12M 3.07% 12

Other funds holding SIOX

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Ziff Brothers Investments's SIOX Position: Q3 2016 in Review

Ziff Brothers Investments held its Sio Gene Therapies Inc. Common Stock (SIOX) position steady in Q3 2016 at 119,997 shares worth $13.4M. The position accounts for 5.04% of the portfolio, ranked #12.

Ziff Brothers Investments first reported a position in SIOX in Q2 2016 and has held it in 2 quarters since. 95 funds tracked by Wall St. Rank hold SIOX as of Q3 2016.

  • Ziff Brothers Investments held 119,997 shares of Sio Gene Therapies Inc. Common Stock worth $13.4M as of Q3 2016.
  • Ziff Brothers Investments left its Sio Gene Therapies Inc. Common Stock share count unchanged in Q3 2016.
  • Sio Gene Therapies Inc. Common Stock made up 5.04% of Ziff Brothers Investments's portfolio in Q3 2016, its #12 holding.
  • Ziff Brothers Investments first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2016 and has held it in 2 quarters since.
  • 95 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q3 2016.

Based on Ziff Brothers Investments's 13F filing for Q3 2016, filed 14 Nov 2016.